G. atroviridis Griff. ex T. Anders. 2 claims

Literal values, not normalised. 437,395 distinct spellings cover 11,236,429 claims; only letter case and spacing are merged, so “maize”, “corn” and “Zea mays L.” are three separate entries here. The By organism view merges spellings of one organism through NCBI Taxonomy.

Observationobservedoriginal resultmeasured

Claim · model-written summary

G. atroviridis rind TPC was 2.47±0.42%.

Taxon
G. atroviridis Griff. ex T. Anders.Garcinia atroviridise0
Organ / stage
rinde0
Outcome
TPCe0
Direction
highere0
Value
2.47±0.42%e0

Verbatim

e0

“The TPC of G. mangostana L. rind extract is higher (31.83±3.70%), than G. cowa Roxb.(4.35±0.17%) and G. atroviridis Griff. ex T. Anders. (2.47±0.42%).”

✓ located verbatim in the source · abstract, characters 653–803

Title

DETERMINATION OF THE TOTAL PHENOLICS AND ANTIOXIDANT ACTIVITY IN THE RIND EXTRACTS OF GARCINIA MANGOSTANA L., GARCINIA COWA ROXB., AND GARCINIA ATROVIRIDIS GRIFF. EX T. ANDERS.

REGINA ANDAYANI; FITHRIANI ARMIN; AINUL MARDHIYAH Asian Journal of Pharmaceutical and Clinical Research 2020. doi:10.22159/ajpcr.2020.v13i8.36525

Other claims from this paper (5)
Observationobservedoriginal resultmeasured

Claim · model-written summary

G. atroviridis rind antioxidant activity was 17.61±0.05 μM Fe(II)/g.

Taxon
G. atroviridis Griff. ex T. Anders.Garcinia atroviridise0
Organ / stage
rinde0
Outcome
total antioxidant activitye0
Direction
highere0
Value
17.61±0.05 μM Fe(II)/ge0

Verbatim

e0

“Based on the antioxidant activity, G. mangostana L. rind has a higher total antioxidant activity (24.68 μmol Fe(II)/g) than G. cowa Roxb. (18.88±0.12 μM Fe (II)/g and G. atroviridis Griff. ex T. Anders.(17.61±0.05 μM Fe(II)/g).”

✓ located verbatim in the source · abstract, characters 804–1031

Title

DETERMINATION OF THE TOTAL PHENOLICS AND ANTIOXIDANT ACTIVITY IN THE RIND EXTRACTS OF GARCINIA MANGOSTANA L., GARCINIA COWA ROXB., AND GARCINIA ATROVIRIDIS GRIFF. EX T. ANDERS.

REGINA ANDAYANI; FITHRIANI ARMIN; AINUL MARDHIYAH Asian Journal of Pharmaceutical and Clinical Research 2020. doi:10.22159/ajpcr.2020.v13i8.36525

Other claims from this paper (5)